U.S. Representatives John Moolenaar (R-MI) and Debbie Dingell (D-MI) have introduced the Biotech Investment National Security Act (BINSA). The bipartisan bill aims to prevent U.S. capital, intellectual property, and expertise from inadvertently strengthening China's biotechnology sector, which lawmakers argue threatens American economic and national security. By amending the Comprehensive Outbound...
Bristol Myers India R&D Center to be Largest Outside of U.S.
U.S. pharmaceutical giant Bristol Myers Squibb is significantly expanding its research and development operations in India. The company aims to make its newly inaugurated $100 million facility in Hyderabad its largest R&D center outside of the United States by 2025. The Hyderabad site, which was officially opened by CEO Christopher...
Bristol Myers Squibb to Expand Footprint in India
New York based global biopharmaceutical company Bristol Meyers Squibb will invest $100 million to establish a facility in Hyderabad, India, to expand its global drug development and IT capabilities. The firm plans to begin its operations in Hyderabad in the second half of 2023 and employ approximately 1,500 people. According to...